Results 171 to 180 of about 12,294 (211)
Some of the next articles are maybe not open access.
Headache: The Journal of Head and Face Pain, 1976
SYNOPSISSeven women with early menstrual or premenstrual migraine were given CB154 (Bromocriptine) over 15 menstrual cycles. In 12 menstrual cycles only one migraine attack occurred. Bromocriptine in a dose of 1 mg tid. at 4 day intervals was effective in relieving menstrual migraine and major symptoms of the premenstrual syndrome in these patients ...
T. D. R. Hockaday +2 more
openaire +3 more sources
SYNOPSISSeven women with early menstrual or premenstrual migraine were given CB154 (Bromocriptine) over 15 menstrual cycles. In 12 menstrual cycles only one migraine attack occurred. Bromocriptine in a dose of 1 mg tid. at 4 day intervals was effective in relieving menstrual migraine and major symptoms of the premenstrual syndrome in these patients ...
T. D. R. Hockaday +2 more
openaire +3 more sources
Annals of Internal Medicine, 1979
Excerpt To the editor: The excellent and valuable review in the June issue by Drs. Spark and Dickstein, "Bromocriptine and Endocrine Disorders" (1), referred to the potential teratogenicity of this...
Richard L. Elton, Harrison M. Langrall
openaire +2 more sources
Excerpt To the editor: The excellent and valuable review in the June issue by Drs. Spark and Dickstein, "Bromocriptine and Endocrine Disorders" (1), referred to the potential teratogenicity of this...
Richard L. Elton, Harrison M. Langrall
openaire +2 more sources
Immunomodulation by bromocriptine
Immunopharmacology, 1983Treatment of rats with the dopaminergic ergot alkaloid bromocriptine (BRC) inhibited the following immune reactions: contact sensitivity skin reaction to dinitrochlorobenzene (DNCB); antibody formation to sheep red blood cells and to bacterial lipopolysaccharide; adjuvant arthritis; and experimental allergic encephalitis. Immunosuppressive doses of BRC
Eva Nagy +4 more
openaire +3 more sources
Current Medical Research and Opinion, 1982
A double-blind trial was carried out in 9 patients with endogenous depression to compare the effectiveness of bromocriptine (15 mg per day, 4 patients) with that of imipramine (75 mg per day, 5 patients) over a period of 10 weeks. The results of assessments using the Hamilton Rating Scale for Depression showed that both drugs produced comparable ...
N Bouras, P K Bridges
openaire +3 more sources
A double-blind trial was carried out in 9 patients with endogenous depression to compare the effectiveness of bromocriptine (15 mg per day, 4 patients) with that of imipramine (75 mg per day, 5 patients) over a period of 10 weeks. The results of assessments using the Hamilton Rating Scale for Depression showed that both drugs produced comparable ...
N Bouras, P K Bridges
openaire +3 more sources
Resistance to Bromocriptine in Prolactinomas [PDF]
Obstetrical & Gynecological Survey, 1989 Bromocriptine therapy normalizes PRL secretion in most, but not all, patients with prolactinomas. This study was undertaken to determine the mechanism(s) responsible for bromocriptine resistance in patients with a PRL-secreting macroadenomas (n = 5) or microadenomas (n = 3). Their mean basal plasma PRL value was 807 +/- 220 (+/- SE) micrograms/L before
I. Pellegrini +9 more
openaire +3 more sources
Treatment of Acromegaly with Bromocriptine
Australian and New Zealand Journal of Medicine, 1979Summary: Five men and three women with active acromegaly were treated with bromocriptine. After three months' therapy (30 mglday) mean GH during the day decreased by 50% in six out of eight subjects. In the remaining two subjects (non‐responders) GH was persistently over 100 μg/1.
Yeung, RTT, Wang, C, Chan, V
openaire +5 more sources
Bromocriptine in the rett syndrome
Brain and Development, 1990Twelve typical cases of the Rett syndrome and one forme fruste were treated with bromocriptine for six months and then had a washout for two months followed by resumption of the bromocriptine treatment. During the first bromocriptine treatment there were improvements in communication and relaxation in some of the girls: a more regular sleep pattern was
M. Zappella +3 more
openaire +4 more sources
Bromocriptine and Hallucinations
Annals of Internal Medicine, 1984Excerpt To the editor: Vance and associates (1) state in their review on bromocriptine, "Hallucinations have been associated with bromocriptine treatment in patients with Parkinson's disease but ar...
openaire +3 more sources
Bromocriptine and Endocrine Disorders
Annals of Internal Medicine, 1979Excerpt To the editor: Drs. Spark and Dickstein have presented an excellent overview of the role of bromocriptine in the treatment of endocrine disorders (1).
G. M. Besser +3 more
openaire +3 more sources
Bromocriptin-induzierte Pleuropneumopathie
DMW - Deutsche Medizinische Wochenschrift, 2008A 64-year-old man was diagnosed to have Parkinson's disease when aged 42 years and since then has been treated with levodopa and benserazide (up to 875 mg daily). Bromocriptine (up to 35 mg daily) was added to the medication 9 years ago. 3 1/2 years ago he developed exertional dyspnoea (NYHA class II-III) and lost 5 kg in weight.
P. Greminger +4 more
openaire +3 more sources